The OpenAI platformization take feels like the safest bet here (imo it's already the consensus in most SF infra circles - my ttwo cents here:
https://philippdubach.com/posts/how-ai-is-shaping-my-investm...).
The medical MLLM grafting is a much higher-stakes claim. Let’s see if "regulatory-grade" ever actually happens without a full retraining—history suggests the FDA isn't a fan of modular grafts.